About Curis Lifesciences IPO

Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company that specializes in developing, manufacturing, and distributing a diverse range of products.

The company manufactures pharmaceutical products globally and domestically on a loan license or contract basis, as well as for its own brand marketing.

The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya.

Products:

  • General pharmaceutical tablets and capsules
  • Oral liquids
  • External preparations
  • Sterile ophthalmic ointments

The company operates a state-of-the-art manufacturing facility in Sanand, Gujarat, adhering to stringent quality control measures to ensure product safety and efficacy.

As of July 31, 2025, the company has 95 permanent employees.

Competitive Strengths:

  • Experienced Promoters and Management Team
  • Wide range of Products
  • Strategic Location of Manufacturing Facility
  • Scalable Business Model
  • Quality assurance

Curis Lifesciences IPO Subscription Breakdown

Investory CategorySubscription PercentageAmount Raised (₹ Crores)
Qualified Institutional Buyers (QIBs)50%7,70,500 crores
Non-Institutional Investors (NIIs)15%2,31,150 crores
Retail Individual Investors (RIIs)35%5,39,350 crores

Curis Lifesciences IPO Financial Highlights

No Data Found
No Data Found

Curis Lifesciences IPO Strengths & Weaknesses

No Data Found
No Data Found

Curis Lifesciences IPO Important Dates & Issue Details

Allotment DateListing DateRefund Date
12 Nov '2514 Nov '2513 Nov '25
Issue Composition:
Face Value0 per share
Total Issue Size15,41,000 shares (aggregating up to ₹2,56,000 crores)
Fresh IssueNaN shares (aggregating up to To be announced)
Offer for SaleNaN shares of ₹0 (aggregating up to To be announced)
Issue Type
Post-Issue Shareholding Pattern:
Pre-Issue Shareholding shares
Post-Issue Shareholding0 shares

Curis Lifesciences IPO Lot Size and Investment Details

Minimum Lot Size--
Maximum Lot Size (Retail)--

The lot size of Curis Lifesciences ipo has been designed to ensure broad participation while maintaining optimal price discovery.

How to Apply for Curis Lifesciences IPO

  1. Log in to your Choice account
  2. Select IPO
  3. Enter the number of lots and your price
  4. Verify UPI ID
  5. Complete the transaction on your UPI app

Curis Lifesciences IPO Contact & Registrar Details

Contact Details

Address

Address

Phone Number

Phone Number

+91

Email

Email

Website

Website

Registrar Details

Address

Registrar Name

Phone Number

Phone Number

+91

Email

Email

Website

Website

Optivalue Tek Consulting Ltd IPO Lead Manager(s)

Book Running Lead Manager(s)

Curis Lifesciences IPO FAQs

The minimum lot size is 1000 shares with a price band of ₹120 to ₹128 per share, requiring a minimum investment of ₹2,56,000.

Check allotment status on the registrar's website using PAN number or application number after the Curis Lifesciences IPO allotment date.

The listing date of Curis Lifesciences IPO is scheduled for 14 Nov '25 on NSE.

Investment decisions should be based on your risk appetite, financial goals, and a thorough analysis of the company's fundamentals and growth prospects.

Consider factors like company fundamentals, valuation, market conditions, and your investment portfolio before making any investment decision.

You can Curis Lifesciences IPO apply online through your broker's trading platform, mobile app, or through the ASBA facility via internet banking.

The Curis Lifesciences IPO allotment date and listing date are 12 Nov '25and 14 Nov '25, respectively.

Yes, you can apply through your bank's internet banking portal. The funds will remain in your account until allotment, and no need for separate IPO funding.